PCVX vs GILD: Which Stock is Better?
Side-by-side comparison of Vaxcyte Inc and Gilead Sciences Inc in 2026
PCVX
Vaxcyte Inc
$62.35
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | PCVX | GILD | Winner |
|---|---|---|---|
| Market Cap | $9.05B | $170.84B | GILD |
| P/E Ratio | N/A | 20.27 | GILD |
| EPS (TTM) | $N/A | $6.79 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze PCVX
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PCVX or GILD a better investment?
Comparing PCVX and GILD: Vaxcyte Inc has a market cap of $9.05B while Gilead Sciences Inc has $170.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PCVX and GILD?
PCVX (Vaxcyte Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PCVX or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PCVX or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for PCVX.
Which company is more profitable: PCVX or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for PCVX.
Which is the larger company: PCVX or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $170.84B compared to $9.05B for PCVX.
Should I buy PCVX or GILD in 2026?
Both PCVX and GILD have investment merit. PCVX trades at $62.35 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PCVX and GILD stock?
Key differences: Market Cap ($9.05B vs $170.84B), P/E Ratio (N/A vs 20.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).